These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33214404)

  • 1. Acute Motor Axonal Neuropathy Related to COVID-19 Infection: A New Diagnostic Overview.
    Petrelli C; Scendoni R; Paglioriti M; Logullo FO
    J Clin Neuromuscul Dis; 2020 Dec; 22(2):120-121. PubMed ID: 33214404
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy.
    Tard C; Maurage CA; de Paula AM; Cassim F; Delval A; Kuchcinski G; Davion JB; Defebvre L; Bouchiba M; ; Jourdain M; Boucraut J
    Neurophysiol Clin; 2020 Oct; 50(5):397-399. PubMed ID: 33190687
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2.
    Marta-Enguita J; Rubio-Baines I; Gastón-Zubimendi I
    Neurologia (Engl Ed); 2020 May; 35(4):265-267. PubMed ID: 32364124
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome.
    Gigli GL; Vogrig A; Nilo A; Fabris M; Biasotto A; Curcio F; Miotti V; Tascini C; Valente M
    Neurol Sci; 2020 Dec; 41(12):3391-3394. PubMed ID: 33006723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
    Agha Abbaslou M; Karbasi M; Mozhdehipanah H
    Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome after covid-19 infection.
    García-Manzanedo S; López de la Oliva Calvo L; Ruiz Álvarez L
    Med Clin (Barc); 2020 Oct; 155(8):366. PubMed ID: 32718718
    [No Abstract]   [Full Text] [Related]  

  • 7. Guillain-Barré syndrome related to COVID-19 infection.
    Alberti P; Beretta S; Piatti M; Karantzoulis A; Piatti ML; Santoro P; Viganò M; Giovannelli G; Pirro F; Montisano DA; Appollonio I; Ferrarese C
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32350026
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2-Associated Guillain-Barre Syndrome With Good Response to Plasmapheresis.
    Granger A; Omari M; Jakubowska-Sadowska K; Boffa M; Zakin E
    J Clin Neuromuscul Dis; 2020 Sep; 22(1):58-59. PubMed ID: 32833726
    [No Abstract]   [Full Text] [Related]  

  • 9. Post SARS-CoV-2 Guillain-Barré syndrome.
    Arnaud S; Budowski C; Ng Wing Tin S; Degos B
    Clin Neurophysiol; 2020 Jul; 131(7):1652-1654. PubMed ID: 32422529
    [No Abstract]   [Full Text] [Related]  

  • 10. [Guillain-Barré Syndrome Associated with SARS-CoV-2 infection].
    Esteban Molina A; Mata Martínez M; Sánchez Chueca P; Carrillo López A; Sancho Val I; Sanjuan-Villarreal TA
    Med Intensiva (Engl Ed); 2020 Nov; 44(8):513-514. PubMed ID: 32532531
    [No Abstract]   [Full Text] [Related]  

  • 11. Guillain-Barré Syndrome in a Patient With Evidence of Recent SARS-CoV-2 Infection.
    Naddaf E; Laughlin RS; Klein CJ; Toledano M; Theel ES; Binnicker MJ; Nagappan V; Abdulrazzak M; Phelan DM
    Mayo Clin Proc; 2020 Aug; 95(8):1799-1801. PubMed ID: 32753154
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2.
    Bracaglia M; Naldi I; Govoni A; Brillanti Ventura D; De Massis P
    J Neurol; 2020 Nov; 267(11):3166-3168. PubMed ID: 32588185
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel Coronavirus (COVID-19)-Associated Guillain-Barré Syndrome: Case Report.
    Rana S; Lima AA; Chandra R; Valeriano J; Desai T; Freiberg W; Small G
    J Clin Neuromuscul Dis; 2020 Jun; 21(4):240-242. PubMed ID: 32453100
    [No Abstract]   [Full Text] [Related]  

  • 14. Guillain-Barré syndrome following COVID-19: new infection, old complication?
    Padroni M; Mastrangelo V; Asioli GM; Pavolucci L; Abu-Rumeileh S; Piscaglia MG; Querzani P; Callegarini C; Foschi M
    J Neurol; 2020 Jul; 267(7):1877-1879. PubMed ID: 32333166
    [No Abstract]   [Full Text] [Related]  

  • 15. Guillain-Barré syndrome associated with SARS-CoV-2 infection.
    Velayos Galán A; Del Saz Saucedo P; Peinado Postigo F; Botia Paniagua E
    Neurologia (Engl Ed); 2020 May; 35(4):268-269. PubMed ID: 32364123
    [No Abstract]   [Full Text] [Related]  

  • 16. Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome.
    Galassi G; Marchioni A
    Acta Neurol Belg; 2020 Oct; 120(5):1067-1075. PubMed ID: 32696312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain Barre syndrome associated with COVID-19 infection: A case report.
    Sedaghat Z; Karimi N
    J Clin Neurosci; 2020 Jun; 76():233-235. PubMed ID: 32312628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
    Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
    Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is COVID-19-related Guillain-Barré syndrome different?
    Gupta A; Paliwal VK; Garg RK
    Brain Behav Immun; 2020 Jul; 87():177-178. PubMed ID: 32445789
    [No Abstract]   [Full Text] [Related]  

  • 20. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection.
    Chan JL; Ebadi H; Sarna JR
    Can J Neurol Sci; 2020 Nov; 47(6):852-854. PubMed ID: 32468972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.